Relmada Therapeutics says CMO-Urology Raj S. Pruthi departs

PUBT · 1d ago
Relmada Therapeutics says CMO-Urology Raj S. Pruthi departs
  • Relmada Therapeutics’ Chief Medical Officer – Urology, Raj S. Pruthi, left the company on Sept. 3, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Relmada Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-097851), on September 08, 2026, and is solely responsible for the information contained therein.